METis TechBio

Hangzhou, China · Founded 2020 · In IPO Registration

Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. METis TechBio is based in Hangzhou, China and was founded in 2020. It has raised $315 million.

Last price · $/share

—

Implied valuation

—

Total raised

$314.7M

Last round

—

How much has METis TechBio raised?

$314.7Macross 0 recorded rounds

Free account

More of METis TechBio with a free account

·The complete investor list: 19 names
·Watch METis TechBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

METis TechBio investors

19 investors are on record for METis TechBio, including HSG (Hong Kong), CICC Capital, Beijing State-owned Capital Operation and Management and 5Y Capital.

For fundraisers

Raising for a company like METis TechBio?

19 investors have backed METis TechBio.

See all 19 investors →

Frequently asked about METis TechBio

How much has METis TechBio raised?: METis TechBio has raised $314.7M in total across 0 recorded funding rounds.